Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finke

Showing results (251-260 of 270) with videos related to

Pageof 27
Sort By:
Leukemia|April 28, 2016
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working PartyM Sobh, M Michallet, G Gahrton, et al.
Bone Marrow Transplantation|July 30, 2013
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practiceT Ruutu, A Gratwohl, T de Witte, et al.
Bone Marrow Transplantation|October 12, 1999
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune DiseaseA Tyndall, A Fassas, J Passweg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)S Dietrich, A Boumendil, H Finel, et al.
Leukemia|November 16, 2016
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)K Fritsch, B Kasenda, E Schorb, et al.
Bone Marrow Transplantation|March 21, 2017
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromesR Martino, A Henseler, M van Lint, et al.
Bone Marrow Transplantation|July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cellsH D Ottinger, E Albert, R Arnold, et al.
Bone Marrow Transplantation|November 22, 2023
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMTV Potter, L Gras, L Koster, et al.
Bone Marrow Transplantation|September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working partyC Scheid, L de Wreede, A van Biezen, et al.
Bone Marrow Transplantation|December 13, 2016
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow TransplantationM van Gelder, L C de Wreede, M Bornhäuser, et al.
Pageof 27

Showing results (251-260 of 270) with videos related to

Sort By:
Pageof 27
Leukemia|April 28, 2016
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working PartyM Sobh, M Michallet, G Gahrton, et al.
Bone Marrow Transplantation|July 30, 2013
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practiceT Ruutu, A Gratwohl, T de Witte, et al.
Bone Marrow Transplantation|October 12, 1999
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune DiseaseA Tyndall, A Fassas, J Passweg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)S Dietrich, A Boumendil, H Finel, et al.
Leukemia|November 16, 2016
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)K Fritsch, B Kasenda, E Schorb, et al.
Bone Marrow Transplantation|March 21, 2017
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromesR Martino, A Henseler, M van Lint, et al.
Bone Marrow Transplantation|July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cellsH D Ottinger, E Albert, R Arnold, et al.
Bone Marrow Transplantation|November 22, 2023
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMTV Potter, L Gras, L Koster, et al.
Bone Marrow Transplantation|September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working partyC Scheid, L de Wreede, A van Biezen, et al.
Bone Marrow Transplantation|December 13, 2016
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow TransplantationM van Gelder, L C de Wreede, M Bornhäuser, et al.
Pageof 27